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ABSTRACT
Objective: To evaluate the effect of 10% Emblica officinalis irrigation, which has anti-inflammatory, antioxidative,
and antimicrobial activities, adjunctive to scaling and root planing (SRP) for treatment of chronic periodontitis.
Methods: Sixty-six patients were randomly assigned to the negative control group (SRP+saline irrigation; n=22),
positive control group (SRP+chlorhexidine irrigation; n=22), and test group (SRP+10% E. officinalis irrigation;
n=22). Plaque index (PI), gingival index (GI), probing pocket depth (PPD), clinical attachment level (CAL), and
sulcus bleeding index (SBI) were monitored ≤3 months post-therapy. Results: There were significantly greater
reductions in the mean PI, PPD, and SBI but a greater mean CAL at 3 months post-therapy in the test group than in
the negative control (p<0.05). Compared with the positive control, the test group demonstrated greater reduction in
SBI but comparable improvements in PI, GI, CAL, deep pockets (PPD≥5–6 mm, ≥7 mm), and sites with CAL ≥6
mm at 3 months post-therapy (p>0.05) but less reduction in the mean PPD (p<0.05). Conclusions: E. officinalis
10% irrigant adjunctive to SRP improved periodontal healing without side effects and may be an alternative to
chlorhexidine for chronic periodontitis treatment.
Keywords: chlorhexidine; chronic periodontitis; Emblica officinalis; root planing
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INTRODUCTION
Bacterial plaque is the principal etiological factor in
the initiation of inflammatory periodontal diseases,
and the destructive host responses triggered by
microbial pathogens exaggerate the already existing
condition, which results in connective tissue loss
characterizing the inflammatory periodontal diseases.1
The key element in periodontal therapy is to achieve
significant reduction or eradication of suspected
periodontal pathogens and modulation of destructive
host responses.
Chlorhexidine has been extensively used as an adjunct
to conventional mechanical treatment for chronic
periodontitis. Its use, however, is limited by various
side effects, including development of resistance,
decrease in salivary secretions, acceleration in calculus

accumulation, altered taste perception, and teeth
staining. Researchers are increasingly turning their
attention to phyto-therapeutic agents and looking for
new leads to develop better drugs against multidrugresistant microbial strains. Bacteria are less likely to
develop resistance to these natural substances, which
should be safer for patients and cause fewer side
effects.2
Emblica officinalis Gaertn. (E. officinalis) (a.k.a.
Phyllanthus emblica Linn.) belongs to the family
Euphorbiaceae. All parts of the plant are useful in
treating various ailments, but the fruit is of immense
value in various traditional systems of medicine
because it possesses a wide array of activities, such as
antibacterial, anti-inflammatory, analgesic, antioxidant,
immunomodulator y, antibacterial, antipyretic,
antidiabetic, hypolipidemic, cardioprotective, and
15
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written informed consent was obtained from each
patient after explaining the procedure in detail along
with the advantages and disadvantages in the patient’s
own language.

antiresorptive properties.3-10 E. officinalis fruit is one
of the richest sources of vitamin C (600mg/100g)
and contains water, proteins, carbohydrates, fibers,
minerals, zinc, chromium, copper, and gallic acid. The
antimicrobial property of E. officinalis fruit is attributed
mainly to flavonoids, phenols, saponins, and tannins.11
Saponins and tannins have been proven to have potent
antimicrobial properties.11 Phenolic compounds
of E. officinalis also ameliorate acute and chronic
inflammation because of their modulatory action on
free radicals and by affecting the cyclooxygenase
(COX) pathway, specifically prostaglandins.3,12 In
a clinical randomized controlled trial, Grover et
al. recently demonstrated that adjunctive use of
E. officinalis sustained-release gel with nonsurgical
periodontal treatment may improve periodontal
tissue healing and/or treatment outcomes of chronic
periodontitis.13

This st udy was a single-center, double-blind,
randomized controlled clinical trial. Sixty-six patients
diagnosed as having chronic periodontitis were enrolled
in the study by one investigator (SG) and randomly
allocated by using a computer-generated table to the
test group (SRP+10% E. officinalis irrigation), positive
control group (SRP+0.2% chlorhexidine irrigation), and
negative control group (SRP+0.9% saline irrigation) by
another investigator (ST).
Periodontal examination
After inclusion in the study, all patients underwent a
full-mouth periodontal examination in a standardized
manner that used a mouth mirror, tweezers, a Williams
probe (Hu-Friedy, Chicago, IL, USA), and an explorer.
The following parameters were considered: primary
outcome variables, including probing depth (PD)
and clinical attachment level (CAL); and secondary
outcome variables, including plaque index (PI),
gingival index (GI), and sulcus bleeding index (SBI).1517
Each tooth was assessed at four sites (mesiobuccal,
midbuccal, distobuccal, and midlingual) for PI and GI
and at six sites (mesiobuccal, midbuccal, distobuccal,
mesiolingual, midlingual, and distolingual) for PD,
CAL, and SBI during the periodontal examination.

After a careful search of the literature, we did not
find any studies that have compared the effect of E.
officinalis irrigant with chlorhexidine in the treatment
of chronic periodontitis. Thus, the present study
aimed to evaluate the effectiveness of an indigenously
prepared 10% E. officinalis hydroalcoholic extractbased irrigant used as an adjunct to scaling and
root planing (SRP) in the management of chronic
periodontitis and to compare it with that of 0.2%
chlorhexidine and 0.9% saline solution adjuncts to SRP.

Intra-examiner reproducibility was determined for
10% of the patients to rule out any variability in the
measurements. Each participant was assessed twice,
and measurements were repeated within 2 days. The
reproducibility of the data collection was determined
for each site. Repeated measurements were recorded
with >90% accuracy, and the k values ranged from
0.82 to 0.86.

METHODS
This study was conducted in the Department of
Periodontics and Oral Implantology, Post Graduate
Institute of Dental Sciences (PGIDS), Rohtak, in
collaboration with the College of Pharmacy and
Department of Microbiology, Post Graduate Institute
of Medical Sciences (PGIMS), Rohtak. This study was
designed according to the ethical standards outlined in
the 1964 Declaration of Helsinki, as revised in 2008.
The study was approved by the Institutional Review
Board, PGIDS, Rohtak (PGIDS/2013/IEC/87) and
ethical committee of PGIDS, Rohtak.

Preparation of E. officinalis extract
The authenticated E. officinalis fruits (herbal garden,
College of Pharmacy, PGIMS, Rohtak) were collected,
washed, and shade dried at room temperature.
E. officinalis extract was prepared by using the
methodology according to Kokate as described in our
previous study (Grover et al.), and a 10% concentration
of E. officinalis extract was finalized for subgingival
irrigation in the present study also.13,18

Study population
The study patients were selected from systemically
healthy individuals attending the regular outpatient
Department of Periodontics and Oral Implantology,
PGIDS, Rohtak. The inclusion criteria were systemically
healthy patients with chronic periodontitis, age
≥30 years, and ≥20 teeth.14 The exclusion criteria
were the presence of systemic illnesses that affect
the outcome of periodontal therapy, such as diabetes
mellitus; immunocompromised states; history of
periodontal therapy in the preceding 6 months; prior
use of antibiotics or anti-inflammatory drugs within
the last 6 months; allergy to chlorhexidine; aggressive
periodontitis; pregnancy or lactating women; smokers
(current/former); and alcohol or drug abuse. Prior

E. officinalis irrigant was prepared by dissolving
weighed E. officinalis extract (20g) in 200mL of
distilled water. The pH of the resultant solution was
2.5. Sodium hydroxide buffer (Titan Biotech Limited,
Bhiwadi, India) was added to adjust the pH to neutral.
The pH was measured by using a pH meter (Thermo
Electron Corporation, Beverly, MA, USA).
Periodontal treatment
The patients received nonsurgical treatment in the
form of full-mouth supragingival and subgingival
16
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Table 1. Demographic data and periodontal parameters at baseline.
Parameters
Age

Mean±SD
Minimum
Maximum

Sex

Male

Negative control
group
(n=20)
38.65±8.165
30
58

Positive control
group
(n=20)
38.20±5.996
30
52

Test group
(n=20)

n=11
(Mean age=
37.86±6.38
Max.=48
Min.=30)

n=9
(Mean age=
39.571±7.53
Max.=52
Min=30)

n=9
(Mean age=
37.0±5.802
Max.=44
Min.=30)

n=11
(Mean age=
40.286±2.98
Max.=45
Min.=36)
Mean±SD:
1.87±0.480
Median: 1.73
Min.:1.18
Max.:2.88
Mean±SD:
2.039±0.262
Median: 2.0
Min.: 1.75
Max.: 2.88
Mean±SD: 3.4±0.854
Median: 3.237
Min.: 2.13
Max.: 4.99

n=11
(Mean age=
40.143±9.459
Max.=55
Min.30)
Mean±SD:
1.993±0.334
Median: 1.956
Min.: 1.55
Max.:2.70
Mean±SD:
2.154±0.319
Median: 2.0
Min.: 1.70
Max.: 3.0
Mean±SD:
3.574±0.549
Median: 3.386
Min.: 3.03
Max.: 4.82
Mean±SD:
3.829±0.628
Median: 3.535
Min.: 3.01
Max.: 4.99
Mean±SD:
3.069±0.916
Median: 3.118
Min.: 1.48
Max.: 4.85

Female

Periodontal
parameters

n=9
(Mean
age= 42.57±9.83
Max.=58
Min.=39)
Plaque index
Mean±SD:
(PI)
1.923±0.403
Median: 1.906
Min.: 1.16
Max.: 2.80
Gingival index Mean±SD:
(GI)
2.081±0.241
Median: 2.0
Min: 1.86
Max: 2.76
Probing pocket Mean±SD:
depth
3.09±0.497
(PPD)
Median:3.0
Min.:2.35
Max.:4.06
Clinical
Mean±SD:
attachment level 4.072±1.376
(CAL)
Median: 3.64
Min.: 2.23
Max.: 7.39
Sulcus bleeding Mean±SD:
index
3.12±0.767
(SBI)
Median: 2.99
Min.: 1.151
Max.: 4.10

Mean±SD:
3.582±0.956
Median: 3.42
Min.: 2.34
Max.: 6.04
Mean±SD:
3.071±0.777
Median: 2.845
Min.: 1.47
Max.: 4.92

38.05±6.832
30
56

p-value
0.85

0.92

0.64
0.12

0.11

0.71

0.06

0.10

p<0.05 indicates significance (by Kruskal–Wallis analysis);  Negative control group: SRP +subgingival saline irrigation;
Positive control group: SRP+subgingival chlorhexidine irrigation; Test group: SRP+subgingival E. officinalis irrigation

SRP in two sessions using manual instruments and
an ultrasonic scaler (Suprasson® P5 Booster; Satelec,
a Division of A-tec, Newberg, OR, USA) by one
investigator (SG). A single application of subgingival
irrigation with 0.9% saline, 0.2% chlorhexidine, or 10%
E. officinalis irrigant was given to each patient in the
negative control group, positive control group, and test
group, respectively, on the day of completion of SRP
by another investigator (ST). The subgingival irrigation
was accomplished by applying 5mL of irrigant in
both arches by using a syringe and blunted needle.
The patients were instructed to use only mechanical

techniques to clean teeth during the study period,
and mouthwashes and/or antimicrobials were not
prescribed. All periodontal parameters were recorded
at baseline and after 2 and 3 months of follow-up by a
single periodontist (SG).
Statistical analysis
Assuming a fairly normal distribution of the samples, a
minimum sample of 18 patients per group was required
to detect a clinically significant difference in PPD and
CAL with effect size (d)=1 (a difference in CAL or PPD
of 1 mm with a standard deviation of 1 between two
17
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Table 2. Intragroup comparison of whole-mouth clinical parameters in the positive control group, test group, and negative
control group at baseline and after 2 and 3 months
PERIODONTAL
PARAMETERS

Plaque Index

Gingival Index

Probing Pocket
Depth

Clinical
Attachment Level

Sulcus Bleeding
Index

Groups

Baseline

2 months

p-value
(0–2
mo.)

3 months

p-value
(0–3 mo.)

p-value
(2–3 mo.)

Negative
1.923±0.403
control group
Positive control 1.87±0.480
group
Test group
1.993±0.334

1.184±0.522

0.00*

0.673±0.237

0.00*

0.00*

0.756±0.348

0.00*

0.573±0.269

0.00*

0.00*

0.871±0.549

0.00*

0.674±0.192

0.00*

0.00*

Negative
2.081±0.241
control group
Positive control 2.039±0.262
group
Test group
2.154±0.319

1.622±0.337

0.00*

1.440±0.251

0.00*

0.00*

1.449±0.360

0.00*

1.258±0.250

0.00*

0.00*

1.586±0.173

0.00*

1.366±0.145

0.00*

0.00*

Negative
3.09±0.497
control group
Positive control 3.4±0.854
group
Test group
3.574±0.549

2.681±0.561

0.00*

2.626±0.618

0.00*

0.00*

2.740±0.715

0.00*

1.997±0.56

0.00*

0.00*

2.676±0.493

0.00*

2.508±0.574

0.00*

0.00*

Negative
4.072±1.376
control group
Positive control 3.582±0.956
group
Test group
3.829±0.628

3.576±1.431

0.00*

3.35±1.575

0.00*

0.00*

3.006±0.896

0.00*

2.593±0.763

0.00*

0.00*

3.135±0.735

0.00*

2.852±0.683

0.00*

0.00*

Negative
3.12±0.767
control group
Positive control 3.071±0.777
group
Test group
3.069±0.916

1.513±0.688

0.00*

0.979±0.959

0.00*

0.00*

1.185±0.884

0.00*

0.671±0.501

0.00*

0.00*

0.926±0.883

0.00*

0.365±0.153

0.00*

0.00*

p<0.05 indicates significance (by Wilcoxon signed-rank test analysis)

and 3 months posttreatment (Figure 1). No adverse
effect was observed during or after the treatment with
E. officinalis extract irrigation. Healing was uneventful.

groups), 80% power, and a 0.05 level of significance.
To further compensate for dropouts, 22 patients were
assigned to each group. The distribution of the data
for all parameters was analyzed by performing the
Kolmogorov-Smirnov test. For non-normal distribution
of data, differences among the test, positive control,
and negative control groups at baseline were analyzed
by using the Kruskal-Wallis test. The comparison of
periodontal parameters between baseline, 2 months,
and 3 months within a group were analyzed by using the
Freidman test followed by the Wilcoxon signed-rank
test. Differences between the groups for improvements
in parameters were assessed by using the KruskalWallis test followed by the Mann-Whitney U test. All
statistical analyses were two tailed with a threshold
for significance of p<0.05 and were calculated by
using standard statistical software (SPSS, v.21.0 for
Windows; IBM, Chicago, IL, USA).

Table 1 highlights the demographic and baseline
clinical characteristics of the study groups. There were
no statistically significant differences between the ages
and sex distributions between the two groups (p>0.05).
Statistically insignificant differences in whole-mouth
PI, GI, PPD, CAL, and SBI were found among the
groups at baseline (p>0.05).
Table 2 shows that there were statistically significant
improvements in all clinical parameters from baseline
to 2 and 3 months post-therapy in all test and control
groups (p<0.05).
Table 3 shows the intergroup comparisons among the
clinical parameters at all time points posttreatment. PI:
The test group showed reductions in plaque scores at
3 months post-therapy similar to those in the negative
and positive control groups. GI: Similar reductions at
all time points were observed among the test group and

RESULTS
Sixty-six patients participated in the study. Out of
these, 60 patients completed both follow-ups at 2
18
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Table 3. Intergroup comparisons of improvements (∆) in full-mouth clinical parameters (Mean±SD) between the positive
control group, test group, and negative control group

Baseline to 2
months

Baseline to 3
months

2–3 months

Positive cont rol Test group
group

P1-value

Negative control P2-value
group

P3-value

∆PI

1.114±0.374

1.122±0.264

0.86

0.739±0.335

0.00*

0.00*

∆GI
∆PPD

0.590±0.375
0.676±0.424

0.538±0.233
0.899±0.464

0.32
0.12

0.459±0.432
0.409±0.432

0.35
0.00*

0.22
0.04*

∆CAL

0.576±0.44

0.694±0.39

0.34

0.404±0.65

0.01*

0.09

∆SBI

1.665±0.907

2.143±0.671

0.04*

1.558±0.563

0.00*

0.98

∆PI
∆GI
∆PPD

1.297±0.468
0.781±0.386
1.420±0.712

1.319±0.312
0.758±0.246
1.066±0.459

0.67
0.62
0.01*

1.25±0.386
0.641±0.307
0.464±0.563

0.64
0.39
0.00*

0.96
0.24
0.00*

∆CAL

1.014±0.546

0.977±0.397

0.62

0.542±0.577

0.00*

0.00*

∆SBI

2.178±0.711

2.704±0.899

0.04*

2.092±0.816

0.04*

0.77

∆PI

0.183±0.232

0.197±0.249

0.98

0.511±0.425

0.00*

0.00*

∆GI
∆PPD

0.191±0.192
0.746±0.443

0.22±0.134
0.168±0.162

0.60
0.00*

0.182±0.264
0.055±0.453

0.10
0.09

0.44
0.00*

∆CAL
∆SBI

0.438±0.456
0.513±0.693

0.283±0.298
0.562±0.356

0.12
0.41

0.225±0.248
0.534±0.726

0.58
0.90

0.05*
0.62

*p<0.05 indicates significance (by Mann–Whitney U test analysis).
p1=Positive control and test groups.
p2=Negative control and test groups.
p3=Positive control and negative control groups.

positive and negative control groups. PPD: Compared
with the negative control group, the test group showed
statistically significant reductions at 2 and 3 months
post-therapy. Similar reductions were observed at
2 months post-therapy in the test and positive control
groups, whereas the positive control group showed a
statistically significant reduction after 3 months. CAL:
Compared with the negative control group, the test
group showed statistically significant gains at 2 and
3 months post-therapy. The test group and positive
control group exhibited similar CAL gains at 2 and
3 months posttreatment. The positive control group
showed greater reductions than those in the negative
control group after 3 months. SBI: The test group
showed significantly greater reductions in SBI than
those in the positive and negative control groups at 2
and 3 months for respective treatments.
Table 4 shows that the test group and positive control
group had statistically significant greater reductions in
the number of sites with moderately deep pockets (PPD
of 5–6mm) than those in the negative control after 2 and
3 months of therapy (p<0.05), whereas the test group
exhibited greater reduction in the moderately deep
pockets than that in the positive control group. The test

group and positive control group showed statistically
significant greater reductions in the sites with CAL
≥6mm than those in the negative control group after
2 and 3 months of therapy (p<0.05), whereas the test
and positive control groups exhibited similar reductions
(p>0.05).

DISCUSSION
E. officinalis Geartn. is arguably one of the most
important plants in traditional systems of medicine.
Various parts of the plant, particularly the fruit,
possess a number of compounds (phenolic compounds,
saponins, tannins, and f lavonoids) with varied
medicinal properties that may be benef icial in
the treatment of various chronic diseases, such as
periodontitis. The E. officinalis extract used in this
study has been generally recognized as safe for its
intended use by the U.S. Food and Drug Administration
as per 21 CFR 170.36 (2009).
When compared with the saline irrigation group, the
E. officinalis irrigation group showed greater reductions
in PPDs, SBIs, % of deep pockets with PPD=5–6mm,
19
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Table 4. Intergroup comparison of percentage improvements (∆) in the number of moderately deep (PPD=5-6mm) and deep
pockets (PD>7mm) and in the number of sites with CAL ≥6mm, pre- and post-therapy (Mean±SD) between the positive control
group, test group, and negative control group.
Period
Baseline
to 2
months

Baseline
to 3
months

2–3
months

Parameters Positive control
group
∆PPD=5– 60.787±34.067
6 mm.
∆PPD≥7
47.656±47.627
mm.
∆CAL≥6
54.507±38.878
mm.
∆PPD=5– 89.734±19.552
6 mm.
∆PPD≥7
57.712±49.133
mm.
∆CAL≥6
70.203±36.642
mm.
∆PPD=5– 66.877±42.180
6 mm.
∆PPD≥7
16.183±35.564
mm.
∆CAL≥6
37.789±41.01
mm.

Test group

P1-value

P2-value

P3-value

0.05*

Negative control
group
46.082±27.023

80.715±26.053

0.00*

0.16

45.26±48.458

0.90

40.046±40.357

0.86

0.96

60.145±32.008

0.56

31.244±29.816

0.00*

0.09

91.93±18.573

0.52

63.706±29.442

0.00*

0.00*

48.375±49.936

0.56

62.483±38.249

0.30

0.75

75.376±21.674

1.00

45.198±33.216

0.00*

0.03*

52.64±44.323

0.46

37.95±34.444

0.46

0.04*

6.331±20.798

0.56

29.353±28.374

0.00*

0.06

30.665±26.058

0.90

27.873±29.709

0.56

0.90

*p<0.05 indicates significance (by Mann–Whitney U test analysis); p1=Positive control and test groups.; p2=Negative control
and test groups; p3=Positive control and negative control groups.

and CAL ≥6mm and significant gain in CALs at both 2
and 3 months post-therapy. There were nonsignificant
differences in the PIs and GI scores after 3 months
of post-therapy between the E. officinalis irrigation
group and saline group. Improvements in periodontal
primary outcome parameters suggest the role of
possible diverse biological activities of E. officinalis,
such as antimicrobial, anti-inflammatory, antioxidant,
immunomodulatory, and antiresorptive properties.

increases in CALs and reduction in moderately deep
pockets were also more evident in the positive control
group after 3 months of post-therapy. Our results
are consistent with those in studies by Wesley et al.
and Gottumukkala et al. in which they stated that
chlorhexidine had a significantly greater effect on
microbiological parameters and PPD at test sites than
that of saline.20,21 Additional improvements in clinical
parameters in the test group might be possible because
of the various beneficial properties of E. officinalis
extract.

Compared with the chlorhexidine irrigation group, the
E. officinalis irrigation group showed similar reductions
in PIs and gingival inflammation and increases in
CALs at all time points. Regarding PPDs, there was
an insignificant difference in improvements within the
first 2 months post-therapy, but a statistically significant
difference in PPDs was observed between baseline
and 3 months for chlorhexidine. The nonsignificant
improvement in PPD in the first 2 months might
be a result of the cytotoxic and inhibitory effect of
chlorhexidine on the fibroblasts in early stages of
healing, which could delay subsequent fibroblast
attachment and thus regeneration of the periodontium.19
With respect to the SBI and moderately deep pockets,
the E. officinalis group showed better improvements
than did the chlorhexidine group after 2 and 3 months
post-therapy, which suggested anti-inflammatory and
antimicrobial effects of E. officinalis irrigant.

The antimicrobial activity of E. officinalis has been
observed in studies to be active against a range of
bacteria.11,22 According to an in vitro study conducted
by Hasan S et al., E. officinalis fruit inhibited virulence
factors of Streptococcus mutans, sucrose-dependent and
sucrose-independent glass surface adherence, biofilm
formation by S. mutans and biofilm architecture.23 Ni
et al. observed that E. officinalis, through the presence
of pyrogallol and its analogs, can antagonize bacterial
quorum sensing in Vibrio harveyi.24
The spectrum of anti-inf lammatory activity of
E. off icinalis against a variet y of ir ritants in
experimental rat models has been evaluated and found
to be effective in most of these models.3 The mechanism
of anti-inflammatory activity was suggested to be
similar to nonsteroidal anti-inflammatory drugs rather
than to steroidal drugs and credited possibly to its
action on inflammatory mediators through the COX
pathway, especially prostaglandins.3 The reduction

A comparison showed that improvements in PI and
PPD were greater in the positive control group than
in the negative control group at all time points, and
20
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Figure 1: Flow chart of patients through the study
Assessed for eligibility (n=72)

Excluded (n = 15)
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9
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n= 22
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+

First Follow-Up
(after 2 months)
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Second Follow-Up
(after 3 months)
Lost to follow-up (Patients didn’t return up on
follow up): 0

Lost to follow-up (Patients didn’t
return up on follow up): n=0

Lost to follow-up (Patients didn’t
return up on follow up): n=1

Discontinued intervention (n=0)

Discontinued intervention (n=0)

Discontinued intervention (n=0)
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1 from analysis (n=0)
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Figure 1. Flow chart of patients through the study


Excluded from analysis (give

in the modified SBI values in the present study may
support the anti-inflammatory role of E. officinalis
irrigant. Recently, a randomized controlled trial
demonstrated antiplaque and antigingivitis activity of
10% triphala (Terminalia bellirica, Terminalia chebula,
and E. officinalis) similar to that of chlorhexidine in
school children, which further supported the results of
the present study.25
The antioxidant properties of E. officinalis extract have
been studied by Scartezzini et al., and they suggested
that ascorbic acid (0.4% w/w) is present in the fruit

accounts for approximately 45-70% of the antioxidant
activity.26
An in vitro study to demonstrate antiresorptive
activity was conducted by Penolazzi et al., and the
results demonstrated that E. officinalis extracts act
by interfering with NF-KB activity, a transcription
factor involved in osteoclast biology, and thus induce
osteoclast apoptosis.10 The immunostimulatory activity
of the E. officinalis extract has also been validated by
many studies and has been shown to enhance natural
killer cell activity.27 One study reported that a triphala
21
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preparation containing E. officinalis as one of its
components caused a 76.6% reduction in MMP-9 in
adult periodontitis patients.28
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Very few studies have reported the clinical effects
of E. officinalis formulations on oral diseases. Alam
et al. conducted a study on humans to compare the
efficacy of a mouth rinse containing E. officinalis
extract 20mg/mL and Glycyrrhiza glabra 20mg/mL
(HMR), a herbal toothpaste gel containing E. officinalis
extract 20mg/mL and G. glabra 20mg/mL (HTG),
and a chlorhexidine mouth rinse on cariogenic
microorganisms (S. mutans and Lactobacilli species)
and showed that HTG was effective for a longer duration
than those of HMR and chlorhexidine mouth rinse.2
Grover et al. investigated the effect of subgingival
application of indigenously prepared 10% E. officinalis
(Amla) sustained-release gel in deep pockets adjunctive
to SRP on chronic periodontitis in their randomized
clinical trial and found that the gel may be beneficial
in reducing inflammation and periodontal destruction.13
However, they had not compared the clinical efficacy
of E. officinalis with chlorhexidine. In the present
study, irrigation with 10% E. officinalis was performed
as an adjunct to SRP, and its effectiveness was
compared with that of chlorhexidine. The results of
this study showed that significantly greater reduction
in inflammation and improved periodontal healing in
deep pockets was achieved by using E. officinalis than
by using chlorhexidine, whereas improvement in other
periodontal parameters was comparable in the test
and positive control groups in patients with chronic
periodontitis.

CONFLICT OF INTEREST
The authors declare that there were no conflicts of
interest related to this study.

REFERENCES
1.

Page RC, Sch roeder H E. Pathogenesis of
inflammatory periodontal disease. A summary of
current work. Lab Invest. 1976;34:235-49.
2. Alam A, Parvez N, Yadav S, Dang R, Shethy JP.
Comparative evaluation of herbal mouth rinse,
herbal toothpaste gel and chlorhexidine mouth
rinse for carcinogenic bacteria. Continental
Journal of Pharmacology and Toxicology Research
2008;2:19-26.
3. Jaijoy K, Soonthonchareonnon N, Panthong
A, Sireeratawong S. Anti-inf lammatory and
analgesic activities of the water extract from the
fruit of Phyllanthus emblica Linn. International
Journal of Applied Research in Natural Products
2010;3:28-35.
4. Yokozawa T, Kim HY, Kim HJ, Okubo T, Chu
DC, Juneja LR. Amla (Emblica officinalis Gaertn.)
prevents dyslipidaemia and oxidative stress in the
ageing process. Br J Nutr. 2007;97:1187-95.
5. Kaur P, Robin, Makanjuola VO, Arora R, Singh
B, Arora S. Immunopotentiating significance of
conventionally used plant adaptogens as modulators in biochemical and molecular signalling
pathways in cell mediated processes. Biomed
Pharmacother. 2017;95:1815-29.
6. Sr i k u m a r R , Pa r t h a sa r at hy NJ, Sh a n k a r
EM, Manikandan S, Vijayakumar R, Thangaraj R,
Vijayananth K, Sheeladevi R, Rao UA. Evaluation
of the growth inhibitory activities of Triphala
against common bacterial isolates from HIV
infected patients. Phytother Res. 2007;21:476-80.
7. Timbadiya MJ, Nishteswar K, Acharya R, Nariya
MB. Experimental evaluation of antipyretic and analgesic activities of Amalakyadi Gana:
An ayurvedic formulation. Ayu. 2015;36:220-4.
8. Suryanarayan P, Saraswat M, Petrash JM, Reddy
GB. Emblica officinalis and its enriched tannoids
delay streptozotocin-induced diabetic cataract in
rats. Mol Vis. 2007;13:1291-7.
9. Golechha M, Bhatia J, Ojha S, Arya DS. Hydroalcoholic extract of Emblica officinalis protects against kainic acid-induced status epilepticus
in rats: evidence for an antioxidant, anti-inflammatory, and neuroprotective intervention. Pharm
Biol. 2011;49:1128-36.
10. Penolazzi L, Lampronti I, Borgatti M, Khan MTH,

Our study design had the following strengths: the
strict inclusion and exclusion criteria and the exclusion
of smokers to evacuate the effect of smoking on
periodontal treatment outcomes. However, there were
also some study limitations: the bioactive components
present in E. officinalis extract were not studied; none
of the biochemical markers were assessed either in
serum or gingival crevicular fluid; the substantivity
of the test irrigant could not be evaluated; and only a
single concentration of E. officinalis irrigant was used
in the study.

CONCLUSION
To summarize, E. officinalis fruit (hydroalcoholic)
extract-based irrigant effectively improved periodontal
parameters associated with periodontal healing in the
treatment of chronic periodontitis when used as an
adjunct to conventional mechanical therapy and may
provide an alternative to chlorhexidine in nonsurgical
periodontal therapy. Future longitudinal multicentered
studies with different concentrations of E. officinalis
subgingival irrigations are required to validate these
results.

22

Journal of Dentistry Indonesia 2018, Vol. 25, No.1, 15-23

11.

12.

13.

14.
15.
16.
17.
18.
19.

20.

Zennaro M, Piva R, Gambari R. Induction of
human primary osteoclasts treated with extracts
from the medicinal plant Emblica officinalis. BMC
Complement Altern Med. 2008;8:1-7.
Kumar A, Tantry BA, Rahiman S, Gupta U.
Comparative study of antimicrobial activity
and phytochemical analysis of methanolic and
aqueous extracts of the fruit of Emblica officinalis
against pathogenic bacteria. J Tradit Chin Med.
2011;31:246-50.
Muthuraman A, Sood S, Singla SK. The antiinflammatory potential of phenolic compounds
from Emblica officinalis L. in rat. Inflammopharmacology 2011;19:327-34.
Grover S, Tewari S, Sharma RK, Singh G, Yadav
A and Narula SC. Effect of subgingivally delivered
10% Emblica officinalis gel as an adjunct to scaling
and root planing in the treatment of chronic
periodontitis-A randomized placebo-controlled
clinical trial. Phytother Res. 2016;30:956-62.
Flemmig TF. Periodontitis. Ann periodontal.
1999;4:32-7.
Silness J, Löe H. Periodontal disease in pregnancy.
II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand. 1964;22:121-35.
Loe H, Silness J. Periodontal disease in pregnancy.
I. prevalence and severity. Acta Odontol Scand.
1963;21:533-51.
Mühlemann HR, Son S. Gingival sulcus bleeding-a leading symptom in initial gingivitis. Helv
Odontol Acta. 1971;15:107-13.
Kokate CK. Practical Pharmacognosy. 4th ed. New
Delhi: Vallabh Prakashan; 2008; p. 107-11.
Tsourounakis I, Palaiologou-Gallis AA, Stoute
D, Maney P, Lallier TE. Effect of essential oil
and chlorhexidine mouthwashes on gingival
fibroblast survival and migration. J Periodontol.
2013;84:1211-20.
Wesley SJ. Microbial evaluation of a single
subgingival irrigation with chlorhexidine and
benzydamine in advanced periodontitis. World J
Dent. 2014;5:37-41.

21. Gottumukkala SNV, Koneru S, Mannem S.
Effectiveness of subgingival irrigation of an
indigenous 1% curcumin solution on clinical
and microbiological parameters in chronic
periodontitis patients: A pilot randomized clinical
trial. J Clin Dent. 2013;4:186-91.
22. Nath A, Raghunatha P, Joshi SR. Diversity and
biological activities of endophytic fungi of Emblica
officinalis, an ethnomedicinal plant of India.
Mycobiology 2012;40:8-13.
23. Hasan S, Danishuddin M, Adil M, Singh K,
Verma PK, Khan AU. Efficacy of E. officinalis
on the cariogenic properties of Streptococcus
mutans: A novel and alternative approach to
suppress quorum-sensing mechanism. PLoS one.
2012;7:e40319.
24. Ni N, Choudhary G, Li M, Wang B. Pyrogallol
and its analogs can antagonize bacterial quorum
sensing in Vibrio harveyi. Bioorg Med Chem Lett.
2008;18:1567-72.
25. Chainani SH, Siddana S, Reddy C, Manjunathappa
TH, ManjunathM, Rudraswamy S. Antiplaque and
antigingivitis efficacy of triphala and chlorhexidine
mouth rinse among schoolchildren–a cross-over,
double-blind, randomized controlled trial. Oral
Health Prev Dent. 2014;12:209-17.
26. Scartezzini P, Antognoni F, Raggi MA, Poli F,
Sabbioni C. Vitamin C content and antioxidant activity of the fruit and of the Ayurvedic preparation
of Emblica officinalis. Gaertn. J Ethnopharmacol.
2006;104:113-8.
27. Suresh K, Vasudevan, DM. Augmentation of
murine natural killer cell and antibody dependent
cellular cytotoxicity activities by Phyllanthus emblica, a new immunomodulator. J Ethnopharmacol.
1994;44:55-60.
28. Abraham S, Kumar MS, Sehgal PK, Nitish S,
Jayakumar ND. Evaluation of the inhibitory effect
of triphala on PMN-type matrix metalloproteinase
(MMP-9). J Periodontol .2005;76:497-502.
(Received December 2, 2017; Accepted February 7,
2018)

23

